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Objectives: The increasing global burden of oral cancer has driven much of the focus of research to the determina-
tion of reliable prognostic markers which may have significant effects on survival and the control of post-treatment 
morbidity. This study was undertaken to evaluate tumour associated tissue eosinophilia (TATE) quantitatively in 
oral cancer specimens and observe for its possible association with tumour stage, patterns of locoregional recurren-
ce and overall prognosis.
Study Design: 14 patients undergoing surgical resection for primary oral squamous cell carcinoma (OSCC) were 
subjected to grey scale ultrasonography (USG) to assess tumour dimensions. The findings were compared with the 
cTNM stage initially documented. TATE was evaluated along the invasive tumour front (ITF) using H & E stained 
sections of histopathological specimens for 10 continuous high power fields (HPF) and graded as mild, moderate 
or intense. Patients were followed up over 5 years and observed for patterns of recurrence.
Results: Loco regional recurrence was significantly associated with intense degree of TATE. (p<0.001) cTNM stage 
as well as USG stage did not correlate with the degree of TATE with p=0.419 and 0.772 respectively. None of the 
patients with mild/ moderate dysplasia developed locoregional recurrence within the period of follow up.
Conclusions: Analysis of TATE in OSCC patients may provide an early indication of future locoregional recurren-
ce. Identification of an appropriate biopsy site representing the ITF where TATE analysis can be performed may be 
a simple, inexpensive method of obtaining valuable prognostic information at the time of diagnosis. 
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Introduction
With an annual estimated incidence of around 275,000 
and two-thirds of the cases occurring in developing coun-
tries alone, oral cancer is a matter of serious concern in 
these parts of the world. Oral squamous cell carcinoma 
(OSCC) accounts for more than 90% of all oral cavity 
cancers (1). Poorer prognosis and survival rates for oral 
cancer in developing countries can be largely attributed 
to presentation at a late stage of the disease by patients 
and failure to follow up cases following treatment (2,3). 
Socioeconomic concerns, lack of awareness and diffi-
culty accessing oral health care facilities are some of 
the factors responsible for the overall anosognosic dis-
position of patients. As a result, there is a tendency for 
overtreatment as an attempt to improve cure rates which 
ultimately increases associated post treatment morbidity 
of patients and undermines their quality of life (4,5). 
Overtreatment may also be a result of improper staging 
of oral cancer patients. Clinical methods used for sta-
ging are not sufficient to form the basis for treatment 
planning and adjunctive imaging modalities must be 
considered wherever possible to avoid under or over 
estimation of dimensions. Reliable indicators of locore-
gional recurrence would also greatly improve survival 
rates in OSCC patients (6). Despite the progress made 
in early detection and therapy, early predictors of cancer 
recurrence at the time of diagnosis are still missing for 
oral cancer. 
Tumour associated tissue eosinophilia (TATE) has been 
reported in diverse sites (7-14) including the head and 
neck region and has been used as a prognosticator for 
many human malignancies (15-28). While its presence 
has been associated with a good prognosis in some stu-
dies, (15,23,25) others claim it is an indicator of poor 
prognosis in head and neck cancer (16,20,21).
The aim of our study was to analyse TATE quantitatively 
along the invasive front of the tumour in histopatholo-
gical specimens of OSCC patients and correlate it with 
clinical staging, recurrence patterns and overall progno-
sis. It has already been established that ultrasonography 
(USG) gives an accurate measure of tumour dimensions 
comparable with histological measurements (29). To 
avoid the significant post-operative morbidity caused 
by stage migration, we first confirmed cTNM staging of 
the tumours with ultrasonographic findings before TATE 
analysis.
Material and Methods 
-Patients:
14 patients undergoing surgical resection for primary 
OSCC at M.S. Ramaiah Medical Hospital between 
January 2009 to January 2010 were selected for the 
study out of a total 45 patients initially screened, upon 
fulfilment of inclusion and exclusion criteria. A detailed 
case history was recorded, clinical examination and ne-
cessary investigations were performed and cTNM sta-
ging for the tumours was documented. 
Patients with primary OSCC confirmed by biopsy who 
had not undergone radiotherapy, chemotherapy, or other 
any treatment prior to surgery were included in the stu-
dy. Meanwhile patients with primary tumours at other 
anatomic locations, unresectable tumours and difficulty 
in mouth opening were excluded from the study. A ma-
jor requirement was the availability of tumour tissue for 
microscopic analysis obtained from the invasive tumour 
front (ITF). Thus, incisional biopsies were excluded from 
the study. Clinical follow-up was maintained including 
data on locoregional recurrence and death. Duration of 
follow up was from January 2009 to December 2013.
-Ultrasonographic examination:
A grey scale USG evaluation (GE Volusun 350 at 
7.5MHz) of the primary tumour was performed with an 
intra-oral probe to assess its transverse dimension and 
identify the appropriate biopsy site. 
An incisional biopsy was performed to confirm the diag-
nosis following which the patients underwent surgical 
treatment. 
-TATE analysis:
Paraffin embedded blocks of the tumour tissue were ob-
tained from the archives of the Department of Pathology, 
M.S. Ramaiah Medical Hospital, Bangalore, India and 
the block representing the invasive front of the tumour 
was identified for each patient. 3µ sections were obtai-
ned and stained routinely with Haematoxylin and Eosin 
stain for TATE analysis. Eosinophils at the invasive front 
were counted under a high power objective (x 400) for 
10 continuous high power fields (HPF) using a light mi-
croscope (OLYMPUS C-20 i). The mean values obtai-
ned were then graded according to the criteria given by 
Goldsmith et al.25 In this criteria, score ‘0’ corresponded 
with absence of eosinophils, ‘1+’ with presence of 5 to 
10 eosinophils/HPF, ‘2+’with 10 to 20 eosinophils/HPF, 
‘3+’ with 20 to 30 eosinophils/HPF and ‘4+’ with more 
than 30 eosinophils/HPF. We considered scores ‘0’ and 
‘1+’ as absent/mild eosinophilia, scores ‘2+’ and ‘3+’ as 
moderate eosinophilia and ‘4+’ as intense eosinophilia, 
(Figs. 1-3).
Results
The association between clinical staging, USG staging, 
locoregional recurrence and TATE has been summarized 
in table 1. 
64.3% of the patients were female and 35.7% were male. 
92.9% of the patients were aged more than 50 years with 
an overall age range of 45-76 years. Although, the cli-
nical stage of these patients was underestimated in 10 
cases (71.4%) when compared with USG findings, the-
re were no statistically significant differences between 
the cTNM and USG stages with p=0.131. 7 cases (50%) 
demonstrated mild TATE, 3 cases (21.4%) demonstra-
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Fig. 1. Mild eosinophilia (under 400x magnification). Fig. 2. Moderate eosinophilia (under 400x magnification).
Fig. 3. Intense eosinophilia (under 400x magnification).
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Table 1. Diagnostic clinical manifestations of cGVHD (10).
n indicates the number of patients; p values obtained by Fischer’s exact test; cTNM: Clinical TNM stage; USG stage: Ultra-
sonography stage; TATE: Tumour associated tissue eosinophilia.
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Fig. 4. Association between degree of TATE and locoregional re-
currence. All patients who developed intense TATE belonged to the 


















1. 50 M T2N1Mx III T3N1 III 3 Mild No 
2. 60 F T2N0Mx II T2N0 II 1 Mild No 
3. 58 F T2N0Mx II T2N1 III 2 Mild No 
4. 55 F T1N0Mx I T2N0 II 5 Mild No 
5. 76 M T2N1Mx III T2N1 III 6 Mild No 
6. 55 F T4aN2bMx IV T4N2 IV 6 Mild No 
7. 65 M T1N0Mx I T2N2 IV 4 Mild No 
8. 50 F T1N1Mx II T3N2 IV 18 Moderate No 
9. 75 F T4N1Mx IV T4N1 IV 25 Moderate No 
10. 55 F T4aN0Mx IV T4N1 IV 20 Moderate No 
11. 45 M T1N1Mx III T3N2 IV 44 Intense Yes 
12. 60 M T2N0Mx II T3N0 III 91 Intense Yes 
13. 62 F T4aN0Mx IV T4N1 IV 52 Intense Yes 
14. 58 F T2N0Mx II T3N1 III 39 Intense Yes 
ted moderate TATE and the remaining 4 (28.6%) cases 
showed intense TATE. None of the patients with mild/
moderate TATE showed locoregional recurrence. Loco 
regional recurrence was significantly associated with 
intense degree of TATE with p<0.001 (Table 1). These 
patients were evaluated for TATE after surgical removal 
of the recurrent lesion. All of the 4 specimens showed 
higher values of TATE than the corresponding primary 
OSCC specimens with no change in overall degree of 
TATE. cTNM stage as well as USG stage did not corre-
late with the degree of TATE with p=0.419 and 0.772 
respectively (Tables 2,3).
Table 2. Summary of clinical data and study parameters.
Sr. No.: Serial number; Sex: M- Male, F- Female; cTNM stage: Clinical TNM stage; USG stage: Ultrasonography stage; HPF: High power 



















 44 58 Intense Yes 
12. 60 T2N0Mx T3N0 91 106 Intense Yes 
13. 62 T4aN0Mx T4N1 52 78 Intense Yes 
14. 58 T2N0Mx T3N1 39 55 Intense Yes 
Table 3. TATE values in patients who developed locoregional recurrence. 
Sex: M- Male, F- Female; cTNM stage: Clinical TNM stage; USG stage: Ultrasonography stage; HPF: High power field; TATE: Tumour 
associated tissue eosinophilia .
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Discussion
The complexities of the interactions between carcinoma-
tous tissue and the underlying stroma has been an area 
of prime focus in cancer research with various features 
such as increased angiogenesis, presence of varying de-
grees of inflammatory infiltrates, desmoplastic stromal 
reaction and microinvasion recognized as important 
indicators of the general biology and behaviour of the 
tumour cell population (20). 
The invasive tumour front (ITF) provides a ‘fertile 
ground’ for the assessment of such interactions as it 
houses the most aggressive cells of the tumour popula-
tion, readily demonstrates molecular events of importan-
ce in tumour spread and is also less differentiated than 
the residual parts of the tumour (29). The ITF has gained 
a lot of attention in the past decade as an important prog-
nosticator of human malignancies. 
Eosinophils are bone marrow-derived, tissue-dwelling 
granulocytes found transiently in the blood circulation 
en-route to tissue inflammatory sites. They are mainly 
associated with parasitic infections and allergic diseases 
but are also known to participate in tissue remodelling 
and modulation of the host immune response (30). Their 
presence in intra and peri-tumoural sites has been well 
documented in a number of locations such as larynx, 
pharynx, esophagus, skin, breast, lung, intestine, geni-
tourinary tract and also the oral cavity (16). Although 
mononuclear cells, and to a lesser extent neutrophils, 
are also found in oral cancers, eosinophils when present, 
form the predominant inflammatory cell population (30). 
However their role as well as association with prognosis 
of these tumours remains controversial.
Many have theorized eosinophils to have a tumour pro-
tective role due to secretion of cytotoxic mediators such 
as major basic protein, eosinophil cationic protein and 
eosinophil peroxidase and their ability to increase per-
meability of tumour killing cytokines into tumour cells 
(31). On the other hand, those who believe TATE to pro-
mote tumour growth have attributed this property to the 
active release of 92- kd gelatinase (of the matrix metallo-
proteinases family) which is involved in the breakdown 
of the basement membrane and the extracellular matrix 
(20). Also, a recent observation states that PGE2 which 
is expressed by OSCC and associated with its invasive 
nature shares its precursor with a potent eosinophil che-
motactic molecule, PGD2 (31).
In this study we attempted to analyze TATE along the ITF 
of patients with OSCC. The patients were preoperatively 
subjected to a grey scale USG examination to determine 
the tumour dimensions and were compared with clini-
cal measurements. A number of studies have validated 
the accuracy of tumour size assessment using USG (29). 
The transverse dimensions of the tumour obtained using 
USG were found to be greater than that measured clini-
cally in 50% of the cases, as a consequence of which the 
cTNM stage had to be changed. We observed a strong 
association between intense TATE and locoregional re-
currence. Interestingly, for the patients that did develop 
second primaries, the lesion was surgically excised and 
also analysed for TATE. All of these specimens showed 
a definite increase in the mean TATE/ HPF than that ob-
served in the corresponding primary OSCC tissues. The 
patients are still being followed up on a regular basis.
Previous reports have found significant association bet-
ween the presence of high degrees of TATE and stromal 
invasion in OSCC (20,31). An increased possibility of 
locoregional recurrence was also reported in such pa-
tients by Alrawi et al. (20). A recent study has even es-
tablished the reliability of TATE as a reliable predictor 
of occult lymph node metastasis in clinically N0 OSCC 
patients (28). On the contrary, Dorta et al. (16) and Lore-
na et al. (32) did not find such an association. 
A plausible explanation for this disparity in results of 
various studies could be due to the lack of a standard 
criteria for grading TATE that is universally followed, 
(16) use of biopsy specimens that run the risk of being 
unrepresentative, inadequacy of clinical methods alone 
in determining the tumour stage and the general lack of 
long term follow up of patients. In our study we included 
only those specimens that were obtained after surgical 
resection, where the invasive front of the tumour could 
be identified. We also confirmed clinical staging with ul-
trasonography and observed a 5 year follow up period 
for each of the patients.
Although intact eosinophils are identified with relative 
ease in routine H & E stained sections of tissue, it may 
get difficult to identify these cells in inflamed or fibrous 
tissue which is where special techniques such as auto-
fluorescence and immunohistochemistry are recommen-
ded. Lorena et al. however reported the H & E technique 
to be as reliable as the immunostaining technique for 
identification of eosinophils.32 In our study, eosinophils 
were easy to identify on H & E sections of 3 µ thickness 
but were often obscured in 4-5 µ sections due to overlap-
ping of structures. Thus we studied only 3 µ sections.
Locoregional recurrence develops much earlier than 
metachronous disease and carries the worst prognosis. 
Patients who survive a first encounter with this disease 
have up to a 20 fold increased risk of developing a se-
cond cancer. In developing countries like India, OSCC 
is more prevalent among low socioeconomic status 
groups. Such patients are often lost to follow up and 
do not comply with lifestyle modifications. Thus, early 
identification of recurrence at the time of diagnosis will 
be useful in identifying patients at risk and employing 
customized treatment strategies and follow up policies 
for them (11,12).
The use of adjunctive imaging modalities such as USG 
to confirm the most appropriate biopsy site that should 
include the advancing front of the tumour or ITF may 
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be helpful as TATE analysis can be done even in biop-
sied tumour tissue in such cases and based on the results, 
individualized treatment plans can be formulated. This 
method is simple, cost effective and can be performed 
routinely. Further studies recruiting larger samples are 
required to validate the findings.
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